When PD‐1 (present on T cells and other immune cells) interacts with its ligands PD‐L1 and PD‐L2 (present on tumor cells), the number of receptors on the surface of T cells decreases, making the T cells insensitive to cancer cells. Here, CD274 is linked to neoplasm.